Equity Research Health Information Services

Should You Buy American Well Corporation Stock in 2026?

By CirclFi Research Team · · Updated · 1/13 models active

According to the CirclFi Deep Alpha Valuation Engine, American Well Corporation (AMWL) carries a solid Quality of Company rating of 5.8/10. Trading at $11.75, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.

The short answer: 1 of 1 CirclFi valuation models project upside for American Well Corporation (AMWL) at $11.75 — the model consensus leans bullish, with a Quality Score of 5.8/10 and Value-Trap risk of 39/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 1 of 1 models see upside — majority bullish
  • Quality Score: 5.8/10 — Moderate — mixed signals
  • Value Trap Risk: 39/100 — Low — manageable risk
  • Fair Value Range: $20.94 – $20.94 (0% spread)

Bullish Models

1 / 1

Bearish Models

0 / 1

Quality Score

5.8 /10

Moderate — mixed signals

Value Trap Risk

39 /100
Low

Low — manageable risk

Model Consensus

1 /13
Active Models

Avg. confidence: 57%

What Is the Investment Case for American Well Corporation (AMWL) in 2026?

What Is the Bull Case vs the Bear Case for American Well Corporation (AMWL)?

Bull case versus bear case for American Well Corporation (AMWL) at $11.75, derived from 1 active CirclFi valuation models on 2026-08-27.
Bull case — $20.94 target (+78.3%) Bear case
According to the CirclFi Deep Alpha Valuation Engine, the gap between the market price of $11.75 and the median fair value of $20.94 implies +78.3% upside potential. No active model flags significant downside for AMWL. The Value Trap score of 39/100 still argues for some caution.
According to the CirclFi Deep Alpha Valuation Engine, the Dynamic NAV model targets a fair value of $20.94 (+78.3%), anchoring the bull case with a methodology that provides a differentiated analytical lens.

How Does AMWL Compare to Its Health Information Services Peers?

EVH Evolent Health, Inc.
5.8
CTEV Claritev Corporation
5.6
OMDA Omada Health, Inc.
5.8
ACON Aclarion, Inc.
5.1
SOPH SOPHiA GENETICS SA
5.9
BRGX BioRegenx, Inc.
5.1
HCTI Healthcare Triangle,
4.1
GDRX GoodRx Holdings, Inc
8.1

Valuation data pages: EVH · CTEV · OMDA · ACON · SOPH · BRGX · HCTI · GDRX · WEAV · DOCS · HQY

See full Health Information Services rankings →

Which Other Stocks Score Like AMWL on Quality?

Closest companies to AMWL’s Quality of Company score of 5.8/10, across all industries.

Why Do CirclFi’s 1 Models Disagree on AMWL?

Spread

0%

Fair Value Range

$20.94 – $20.94

A tight 0% spread suggests meaningful convergence, strengthening conviction in the composite estimate.

Most Bullish

Dynamic NAV

$20.94 (+78.3%)

Most Bearish

Dynamic NAV

$20.94 (+78.3%)

What Are the Biggest Risks of Buying AMWL Stock?

Macro/Sector Risk

Health Information Services headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View AMWL Data Page →

So Is American Well Corporation (AMWL) Worth Buying in 2026?

American Well Corporation at $11.75 presents what our engine identifies as a high-conviction opportunity: 1 of 1 models see upside, quality stands at 5.8/10, and the median fair value of $20.94 implies +78.3% return potential. Investors should verify this thesis against their own risk parameters and time horizon.

These are quantitative model outputs, not investment recommendations. American Well Corporation's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About AMWL Stock?

Should I buy AMWL stock right now?

Based on CirclFi's multi-model analysis, 1 of 1 models see upside for AMWL at $11.75. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 5.8/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in American Well Corporation?

Key risks include: limited model coverage (1/13 active), reducing analytical confidence; general market and sector-specific risks affecting Health Information Services companies. Always diversify and consult a financial advisor.

How does AMWL compare to its competitors?

Among Health Information Services peers, AMWL holds a Quality Score of 5.8/10. Comparable companies include EVH (QOC 5.8), CTEV (QOC 5.6), OMDA (QOC 5.8). The relative ranking helps investors identify whether AMWL offers better fundamental quality than alternatives in the same sector.

Is AMWL a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. AMWL's Quality Score of 5.8/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.

What price should I buy AMWL at?

CirclFi does not provide target buy prices or price alerts. However, our 1 active models produce fair value estimates ranging from $20.94 to $20.94. At $11.75, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for AMWL.

View AMWL Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →